Updated February 15, 2026
The Road towards Triple Agonists: Glucagon-Like Peptide 1, Glucose-Dependent Insulinotropic Polypeptide and Glucagon Receptor - An Update
Prepare for your consultation by: Documenting your current rheumatoid arthritis symptoms, disease activity, and treatment history Listing all current medications, including DMARDs, biologics, corticosteroids, and analgesics Noting any comorbidities, particularly diabetes, obesity, cardiovascular disease, or gastrointestinal conditions Being honest about your treatment goals and what has prompted interest in GLP-1 therapy Questions to discuss with your doctor : What is the current evidence for GLP-1 use in rheumatoid arthritis
Retatrutide Side Effects Like many GLP-1 based medications, retatrutide may cause gastrointestinal side effects during dose escalation
Magnesium glycinate or citrate supports bowel regularity and reduces cramping
Although shown to have good results, at present, authorities such as the FDA have approved GLP-1 medicines only as injections or tablets, not patches
